Atea Pharmaceuticals, Inc.
- Last sale
- Nov 2, 2026 · -0.12%
- Market cap
- $330.01M
- 80.3M shares
- Filings
- 319
FY 2021+622.5% FY21 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2022derivedN/M FY22 yoy
Q3 2026N/M FY25 yoy
Q3 2026+47.9% FY25 yoy
- $330.01M
- —
- —
- 1.9×
- —
- —
FY2025 figures · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | $351,367,000 | reported | |
| FY 2020 | 2020-12-31 | $48,633,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $25.52M | $25.52M | — | 79.67M sh | −6.8% | — |
| FY2024 | — | $0.00 | $0.00 | — | 85.53M sh | +1.6% | — |
Pharmaceutical preparations
Atea Pharmaceuticals, Inc. is the 213th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PEPGPepGen Inc.———$350.5MMPLTMapLight Therapeutics, Inc.———$344.9MCYDYCytoDyn Inc.———$338.0M
AVIRAtea Pharmaceuticals, Inc. (this company)———$330.0M
BNTCBenitec Biopharma Inc.———$329.4MENTAEnanta Pharmaceuticals Inc$65.3M3.4%125.4%$325.8MGALTGalectin Therapeutics Inc———$314.7MALTAltimmune, Inc.$41.0K105.0%214,861.0%$312.3MTTRXTurn Therapeutics Inc.———$310.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR